Weedistry
MARCH 7, 2019
Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find. THC and cannabidiol both induce apoptosis in leukemic cell lines.
The Joint Blog
JULY 18, 2019
CBG (cannabigerol): A cannabinoid same as CBD. CBN (cannabinol): A non-intoxicating cannabinoid that is found in small amounts in the hemp plant. In fact, the DEA had in 2006 showed the intention of classifying Kratom as a schedule I drug, thereby outlawing its use along with other drugs like heroin and marijuana.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Cannabis Law Report
JULY 12, 2019
International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.
Cannabis Law Report
MARCH 25, 2019
It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 9, 2006 , 120 Stat. 201, July 27, 2006 , 120 Stat.
Expert insights. Personalized for you.
40 
Let's personalize your content